Deal Announcements

Anthera Accesses $19 Million In Venture Capital

Friday, August 15, 2008 5:32:00 AM PDT | VentureDeal Staff

San Mateo, California --  Anthera Pharmaceuticals announced that it has garnered $19 million in a new round of venture capital financing.

Anthera is focused on the development of clinical treatments for serious and life-threatening inflammatory diseases.

Investors in the round included HBM BioVentures, VantagePoint Venture Partners, Sofinnova Ventures, Pappas Ventures and Mitsubishi Corporation.  The company did not disclose how the proceeds purposes would be specifically used.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1